Insider Transactions in Q4 2025 at Exelixis, Inc. (EXEL)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2025
|
Brenda Hefti SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
30,170
+20.01%
|
-
|
|
Nov 25
2025
|
David Edward Johnson Director |
BUY
Open market or private purchase
|
Indirect |
27,532
+1.74%
|
$1,183,876
$43.12 P/Share
|
|
Nov 21
2025
|
Dana Aftab EVP, Research and Development |
SELL
Bona fide gift
|
Direct |
24,000
-3.61%
|
-
|
|
Nov 21
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
28,043
-6.97%
|
$1,177,806
$42.58 P/Share
|
|
Nov 20
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Indirect |
34,187
-100.0%
|
$1,401,667
$41.85 P/Share
|
|
Nov 20
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
10,000
-2.43%
|
$420,000
$42.11 P/Share
|
|
Nov 17
2025
|
Bob Oliver Director |
SELL
Bona fide gift
|
Direct |
1,044
-2.41%
|
-
|
|
Nov 12
2025
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Indirect |
80,000
-4.46%
|
-
|
|
Nov 12
2025
|
Michael Morrissey President and CEO |
BUY
Bona fide gift
|
Indirect |
101,548
+5.36%
|
-
|
|
Nov 12
2025
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Direct |
101,548
-6.69%
|
-
|
|
Nov 12
2025
|
Stelios Papadopoulos Director |
SELL
Open market or private sale
|
Direct |
100,000
-7.76%
|
$4,300,000
$43.55 P/Share
|
|
Nov 11
2025
|
Mary C Beckerle Director |
SELL
Open market or private sale
|
Direct |
24,622
-29.71%
|
$1,009,502
$41.97 P/Share
|
|
Nov 11
2025
|
Mary C Beckerle Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,784
+11.17%
|
$133,032
$23.24 P/Share
|
|
Nov 11
2025
|
Dana Aftab EVP, Research and Development |
SELL
Open market or private sale
|
Direct |
48,383
-6.78%
|
$2,032,086
$42.5 P/Share
|
|
Nov 11
2025
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Indirect |
160,000
-8.64%
|
-
|
|
Oct 08
2025
|
Dana Aftab EVP, Research and Development |
BUY
Grant, award, or other acquisition
|
Direct |
50,673
+6.63%
|
-
|